CHAPTER
He-C 5000 DEPARTMENTAL MEDICAID PROGRAM
ADMINISTRATION
PART
He-C 5001 PAYMENTS TO NON-PUBLIC
DISPROPORTIONATE SHARE HOSPITALS
He-C 5001.01 Definitions.
(a)
“Audit” means the independent disproportionate share hospital audit
required by federal Medicaid regulations at 42 C.F.R. Part 455, Subpart D.
(b)
“Department” means the New Hampshire department of health and human
services.
(c)
“Disproportionate share non-public hospitals” means, for purposes of
this part, in-state hospitals, licensed under RSA 151, which participate in the
provider network of the State Medicaid managed care program, and which meet the
minimum criteria for disproportionate share hospital payments pursuant to 42
U.S.C. section 1396r-4(d), and in-state hospitals as identified by RSA 167:63,
IV, which meet the requirements for a deemed disproportionate share hospital
under 42 U.S.C. section 1396r-4(b), but do not include government facilities.
(d)
“Disproportionate share payment,” in conformity with relevant provisions
of RSA 167:64, the New Hampshire Title XIX Medicaid State Plan, federal law at
42 U.S.C. section 1396r-4, and federal regulations promulgated thereunder,
means the amount determined by the department and paid to eligible hospitals to
compensate the hospitals for services provided to Medicaid recipients and
uninsured individuals.
(e)
“Uncompensated care” means losses arising from the difference between
the cost of providing inpatient or outpatient hospital services to Medicaid
recipients and to uninsured patients during the year, and the reimbursement
received for those recipients and patients consistent with 42 U.S.C. section
1396r-4(g) and related federal regulations promulgated by the Centers for
Medicare and Medicaid Services.
(f)
“Uncompensated care and Medicaid fund” means the fund established by RSA
167:63 through RSA 167:65, from which payments are made to eligible hospitals
to support their services to Medicaid recipients and uninsured individuals.
(g)
“Uninsured patient care” means inpatient and outpatient hospital
services provided to any individual with no health insurance or source of third
party coverage for services provided to the individual patient during the year.
Uninsured patient care does not include care provided to patients with health
insurance for the services provided in their third party coverage benefit
package but who have unpaid co-pays or deductibles or any other unreimbursed
costs associated with a patient’s out of pocket payment responsibilities for
covered inpatient or outpatient hospital services provided to them.
Source. #5167, EMERGENCY, eff 6-21-91, exp. 10-19-91;
ss by #5249, eff 10-18-91; ss by #6599, eff 10-8-97, EXPIRED: 10-8-05
New. #9814, INTERIM, eff 11-19-10, EXPIRES: 5-18-11;
ss by #9916-A, eff 4-23-11; amd by #10029, INTERIM, eff 11-19-11, EXPIRES:
5-17-12; ss by #10109, eff 5-17-12; ss by #10789, eff 2-21-15; ss by #12468,
eff 1-26-18; amd by #12719, eff 1-29-19
He-C 5001.02 Uncompensated Care Reimbursement System.
(a)
The commissioner of the department shall determine, for each
disproportionate share non-public hospital, its annual disproportionate share
payment to the extent that such funds are available in the uncompensated care
and Medicaid fund.
(b)
The disproportionate share payments shall be made in accordance with RSA
167:64.
(c)
Disproportionate share payments to the disproportionate share non-public
hospitals shall be made at least annually in the fiscal year within which the
uncompensated care funds became available, pursuant to He-C 5001.02, based upon
the availability of funds in the uncompensated care fund.
(d)
Disproportionate share non-public hospitals shall reconcile and submit
repayment in the event of an overpayment or to ensure compliance with state and
federal law and the Medicaid State Plan as approved by the Centers for Medicare
and Medicaid Services.
Source. #5167, EMERGENCY, eff 6-21-91, exp. 10-19-91;
ss by #5249, eff 10-18-91; ss by #6599, eff 10-8-97, EXPIRED: 10-8-05
New. #9814, INTERIM, eff 11-19-10, EXPIRES:
5-18-11; ss by #9916-A, eff 4-23-11; ss by #10029, INTERIM, eff 11-19-11,
EXPIRES: 5-17-12; ss by #10109, eff 5-17-12; ss by #10789, eff 2-21-15
PART He-C
5002 UNCOMPENSATED
CARE FUND REPORTING
REVISION NOTE:
Document
#13165, effective 1-26-21, readopted with amendments the “Annual Medicaid
Uncompensated Care Cost Data Request Form” pursuant to the expedited revisions
to agency forms process in RSA 541-A:19-c. The “Annual Medicaid Uncompensated Care Cost
Data Request Form” is incorporated by reference in He-C 5002.01(a) and also
referenced in He-C 5002.01(b). Document
#13165 contained only the amended form, giving it a new effective date. Since Document #13165 updated the revision date
on the form from “(January 2019 Edition)” to “(January 2021 Edition)”, the revision date was subsequently
updated editorially in He-C 5002.01(a) and (b) to “(January 2021 edition)”. The prior filing affecting rule He-C 5002.01 was
Document #12719, effective 1-29-19, and the effective date of the rule remained
unchanged by Document #13165.
He-C 5002.01 Reporting Requirements.
(a) All disproportionate share non-public
hospitals, as defined in He-C 5001.01(c), shall complete and submit the “Annual
Medicaid Uncompensated Care Cost Data Request Form” (January 2023 edition) as
follows:
(1) To the office of the commissioner, NH
department of health and human services;
(2) Annually, no later than the second to last
Friday in February of each year; and
(3) Signed by the chief financial officer (CFO)
of each hospital.
(b)
Copies of the “Annual Medicaid Uncompensated Care Cost Data Request
Form” (January 2023 edition) may be obtained from the office of the
commissioner, department of health and human services, Concord, NH 03301-6505.
(c) Hospitals shall maintain all data on claims
related to Medicaid and uninsured patients, including Medicare and third-party
liability revenue until such time as directed otherwise by the Department.
Source. #6888, eff 11-21-98, EXPIRED: 11-21-06
New. #9814, INTERIM, eff 11-19-10, EXPIRES:
5-18-11; amd by #9916-A, eff 4-23-11, (para (b)); amd by 9916-B, eff 4-23-11, (para (a)); ss by #10029, INTERIM, eff
11-19-11, EXPIRES: 5-17-12; ss by #10109, eff 5-17-12; ss by #10789, eff
2-21-15; ss by #12468, eff 1-26-18; ss by #12719, eff 1-29-19; (see also
Revision Note at part heading for He-C 5002); ss by #13545, eff 1-28-23
He-C 5002.02 Reconsideration of an Audited
Hospital-Specific DSH Limit.
(a)
A hospital may submit a written request to the department for
reconsideration of its audited hospital-specific DSH limit pursuant to 42
U.S.C. section 1396r-4(j)(2) if the following criteria are met:
(1) The hospital has and submits additional data
that has not been previously considered; and
(2) There has been no redistribution or
recoupment of funds for the fiscal year in question for that hospital or any
other hospital.
(b)
For the fiscal year 2013 audit, which was issued December 31, 2016,
hospitals shall have 13 months from the date of issuance to request
reconsideration.
(c)
For audit reports for fiscal year 2014 and later, hospitals may request
reconsideration within 3 months of issuance of the audit report.
(d)
If, in the auditor’s opinion, the additional data would have a material
impact on the amount paid to the hospital for that year, the auditor shall
conduct a reassessment and issue an addendum, which the auditor shall send to
the department.
Source. #12468, eff 1-26-18
PART He-C
5003 PREMIUM SCHEDULE
Statutory
Authority: RSA 167:3-c, XII
He-C 5003.01 Premium Schedule for Medicaid for Employed
Adults with Disabilities (MEAD).
(a)
Monthly premium calculation shall be determined by combining monthly net
income for initial eligibility, based on current treatment, disregards and
exclusions from income for aid to the permanently and totally disabled (APTD)
and aid to the needy blind (ANB) recipients pursuant to He-W 654, with monthly
Supplemental Security Income (SSI) and shall include deduction of private
health insurance premiums pursuant to He-C 5003.02(b).
(b)
As a condition of eligibility for MEAD, recipients shall pay a monthly
premium.
(c)
The amount of a premium charged to a recipient shall not exceed 7.5% of
the recipient’s net income, and spouse’s net income if residing together, with
combined net income of less than or equal to 450% of the federal poverty level
(FPL).
(d)
Premium payment shall be based on the recipient’s net income, and
spouse’s net income if residing together, relative to the percent of FPL, rounded
up to the next dollar amount, as follows:
(1) Recipients with net income of less than 150%
FPL shall not pay a premium;
(2) Recipients with net income of 150% up to and
including 200% FPL shall pay not more than 7.5% of 150% FPL;
(3) Recipients with net income of more than 200%
up to and including 250% FPL shall pay not more than 7.5% of 200% FPL;
(4) Recipients with net income of more than 250%
up to and including 300% FPL shall pay not more than 7.5% of 250% FPL;
(5) Recipients with net income of more than 300%
up to and including 350% FPL shall pay not more than 7.5% of 300% FPL;
(6) Recipients with net income of more than 350%
up to and including 400% FPL shall pay not more than 7.5% of 350% FPL; and
(7) Recipients with net income of more than 400%
up to and including 450% FPL shall pay not more than 7.5% of 400% FPL.
(e)
Notwithstanding (c) and (d) above, when a recipient’s annual adjusted
gross income as defined by the IRS exceeds $75,000, that recipient shall pay
the full premium identified in (f) below.
(f)
The full premium shall be calculated annually as 7.5% of the recipient’s
adjusted gross income.
(g)
A choice to accept retroactive medicaid coverage for the month(s) prior
to the date of application shall result in a premium payment due for all
retroactive months covered.
(h)
The retroactive premium payment shall be included in the first premium
payment as specified in (i) below.
(i)
The first premium payment shall be billed on the first day of the month
following the month eligibility was determined and applied to the month(s)
following the month non-retroactive eligibility was determined effective.
(j)
Subsequent payments for all months, which shall follow retroactive and
first premium payment month(s), shall be due on the first day of the month and
applied to the current month.
(k)
Premium payments are due by the recipient for every month except for the
first month of non-retroactive coverage.
(l)
A recipient shall be terminated from MEAD for non-payment of premiums
for 2 consecutive months without good cause.
(m)
A recipient who has been terminated from MEAD for non-payment of premium
in accordance with (l) above shall be reinstated if the recipient meets all
other MEAD eligibility criteria in accordance with He-W 641.03 and:
(1) The recipient has paid the past due premiums
in full; or
(2) It has been determined by the premium
collection agency that the recipient has exhausted all available liquid
resources and income with which to pay past due premiums, in accordance with
(n)(3) below.
(n)
Non-payment of premiums for good cause shall:
(1) Not exceed 3 months;
(2) Be available once every 2 years from the date
the last month’s premium was paid; and
(3) Exist only after the recipient has exhausted
all available resources and income with which to pay his or her premium, due to
one of the following:
a. A temporary or unexpected loss of income
lasting for a minimum of 3 months;
b. An uncovered medical expense that prevents
payment of the premium; or
c. A hardship due to:
1. Loss of home;
2. Costs associated with fire/flood;
3. Unexpected high heating bills resulting in a
25% increase over annual cost;
4. Significant car repairs totaling 25% of
current gross monthly income; or
5. Replacement of a refrigerator or stove.
(o)
A good cause determination for non-payment of premium shall be verified
and made by the premium collection agency.
(p)
A 3-month payment plan option shall be available once every 2 years,
from the date of the last month a premium was paid, to ease a financial burden
due to good cause.
(q)
Termination from MEAD shall result from failure to pay in full the
balance owed at the end of the 3-month plan in accordance with (p) above.
Source. #7637, eff 2-1-02; ss by #8237, eff 12-31-04;
ss by #10261, eff 1-25-13
He- C 5003.02 Private Health Insurance.
(a)
Recipients who are eligible for private health insurance through
employment or membership in an organization, at no cost to them, shall be
enrolled in those insurance plans in order to remain eligible for MEAD.
(b)
The amount of any health insurance premium payments paid by a recipient
for the recipient and for the recipient’s spouse or children shall be deducted
from the recipient’s MEAD premium.
Source. #7637, eff 2-1-02; ss by #8237, eff 12-31-04;
ss by #10261, eff 1-25-13
PART
He-C 5004 TELEHEALTH SERVICES
He-C 5004.01 Definitions.
(a) “Current procedural terminology (CPT) code”
and “current dental terminology (CDT) code” means a unique identifying code in
the field of medical or dental nomenclature and designated by the United States
Department of Health and Human Services as the national coding
standard utilized in government and private health insurance programs for reporting
medical and dental services and
procedures.
(b)
“Department” means the New Hampshire department of health and human
services.
(c) “Distant
site” means the location of the health care provider delivering services
through telemedicine at the time the services are
provided.
(d)
“Healthcare common procedure coding system (HCPCS)” means a standardized
coding system used by Medicare that describes services and procedures. HCPCS
includes CPT codes that are used primarily to identify products, supplies, and services not included in the normal CPT
code list, such as ambulance services and durable medical equipment,
prosthetics, orthotics, and supplies (DMEPOS), when used outside a physician’s
office.
(e)
“Medicaid” means the Title XIX and Title XXI programs administered by
the department which makes medical assistance available to eligible
individuals.
(f)
“National correct coding initiative (NCCI) edits” means
standardized coding edits developed by the Centers for Medicare and Medicaid
Services (CMS) to reduce improper coding and prevent inappropriate
payments when incorrect code combinations are reported.
(g)
"Originating site" means the
location of the patient, whether or not accompanied by a health care provider,
at the time services are provided by a health care provider through telehealth,
including, but not limited to, a health care
provider's office, a hospital, or a health care facility, or the patient's home
or another nonmedical environment such as a school-based health center, a
university-based health center, or the patient's workplace.
(h) “Recipient” means any individual
who is eligible for and receiving medical assistance under the medicaid
program.
(i)
“Remote patient monitoring (RPM)” means “remote patient monitoring” as
defined in RSA 167:4-d, II(e) namely “the
use of electronic technology to remotely monitor a patient's health status
through the collection and interpretation
of clinical data while the patient remains at an originating site. Remote
patient monitoring may or may not take place in real time. Remote patient
monitoring shall include assessment, observation, education and virtual visits
provided by all covered providers including licensed home health care providers”.
(j) "Store and forward," means “store
and forward” as defined in RSA 167:4-d, II(f) namely, “as
it pertains to telemedicine and as an exception to 42 C.F.R. section 410.78,
means the use of asynchronous electronic communications between a patient at an
originating site and a health care service provider at a distant site for the
purpose of diagnostic and therapeutic assistance in the care of patients. This
includes the forwarding and/or transfer of stored medical data from the
originating site to the distant site through the use of any electronic device
that records data in its own storage and forwards its data to the distant site
via telecommunication for the purpose of diagnostic and therapeutic assistance”.
(k) “Teledentistry” means the acquisition and
transmission of all necessary subjective and objective diagnostic data through
interactive audio, video, or data communications by a dental provider subject to RSA 317-A:21-e to
a NH Medicaid enrolled dentist at a distant site for triage, dental treatment
planning, and referral.
(l) “Telehealth” means a two-way, real-time interactive communication between a
patient and a physician or medical provider at a distant site through
telecommunications equipment including video, audio, and audio-only equipment.
(m) “Title XIX” means
the joint federal-state program described in Title XIX of the Social Security
Act and administered in New Hampshire by the department under the medicaid
program.
(n)
“Title XXI” means the joint federal-state program described in Title XXI
of the Social Security Act and administered in New Hampshire by the department
under the medicaid program.
Source. #13651,
eff 5-26-23
He-C 5004.02 Recipient Eligibility. All recipients shall be eligible for
telehealth services when:
(a)
Telehealth, including teledentistry, is determined medically necessary
pursuant to He-W 530.01(e); and
(b)
The recipient has consented to using telehealth, including
teledentistry, as a method of receiving services.
Source. #13651, eff 5-26-23
He-C 5004.03 Medical Provider Participation.
(a) Pursuant to
RSA 167:4-d(f), medical providers shall include, but are not limited to the following:
(1) Physicians and physician
assistants, governed by RSA 329 and RSA 328-D;
(2) Advanced practice nurses,
governed by RSA 326-B and registered nurses under RSA 326-B employed by home
health care providers under RSA 151:2-b;
(3) Midwives, governed by RSA
326-D;
(4) Psychologists, governed by
RSA 329-B;
(5) Allied health
professionals, governed by RSA 328-F;
(6) Dentists, governed by RSA
317-A;
(7) Mental health practitioners
governed by RSA 330-A;
(8) Community mental health providers employed by community mental
health programs pursuant to RSA 135-C:7;
(9) Alcohol and other drug use
professionals, governed by RSA 330-C;
(10) Dietitians, governed by
RSA 326-H; and
(11) Professionals certified by the national behavior analyst
certification board or persons performing services under the supervision of a
person certified by the national behavior analyst certification board.
(b)
Medical providers described in He-C 5004.03(a) above, shall be permitted to perform health care services through the use of
all modes of telehealth, including video and audio, audio-only, or other
electronic media.
(c) Each participating medical
provider shall:
(1) Be licensed to practice by the state of New
Hampshire;
(2) Be a NH enrolled Title XIX provider;
(3) Request and obtain prior authorization in
accordance with He-W 531.07 and dental request per He-W 566.07;
(4) Assure
the same rights to confidentiality and security as provided
in face-to-face services; and
(5) Ensure the patient’s informed consent to the use of telehealth and
advise members of any relevant privacy considerations.
(d)
Medical providers shall adhere to the same standards
of clinical practice and record keeping that apply to other covered services.
Source. #13651, eff 5-26-23
He-C 5004.04 Service Limits.
(a)
Telehealth services shall be subject to the same service limits set
forth in He-W 530.03.
(b)
Teledentistry services shall be subject to the same service limits set
forth in He-W 566.04.
Source. #13651, eff 5-26-23
He-C 5004.05 Covered Services.
(a) Telehealth services, provided through a medicaid managed care organization (MCO), as
defined in He-W 506.03(h) shall be furnished in an
amount, duration, and scope that is no less than the amount, duration, and
scope for the same services furnished to recipients under fee-for-service as
defined in He-W 506.03(f).
(b) The following considerations shall apply to RPM,
as defined in He-C 5004.01(i) above, medical conditions that may be treated or monitored by means of RPM include but are not limited to:
(1) Congestive heart failure;
(2) Diabetes;
(3) Chronic obstructive pulmonary disease;
(4) Wound care;
(5) Polypharmacy, mental or behavioral conditions, and technology dependent care such
as the use of continuous oxygen, ventilator care, total parenteral nutrition, or enteral
feeding;
(6) Hypertension;
(7) Pneumonia; or
(8) Patients at high risk of hospitalization.
(c) Medical devices supplied to patients as part
of RPM services shall comply with section 201 of the Federal Food, Drug and Cosmetic Act (FDA) which requires the wirelessly synced device to
be reliable and to transmit data
electronically for interpretation and recommendations automatically rather than
the patient having to self-report to providers.
(d) Telehealth for developmental disabilities
and acquired brain disorder home and community based care waiver services shall
be provided in accordance with the Centers for Medicare and Medicaid’s “Appendix
K: Emergency Preparedness and Response for Home and Community Based (HCBS)
1915(c) Waivers” (effective March 2020 through 6 months after the end of the
federal public health emergency), as available in Appendix A.
(e) Telehealth for choices for independence home
and community based waiver services shall be provided in accordance with the
Centers for Medicare and Medicaid’s “Appendix K: Emergency Preparedness and
Response for Home and Community Based (HCBS) 1915(c) Waivers” (effective March
2020 through 6 months after the end of the federal public health emergency), as
available in Appendix A.
(f)
Telehealth for in home supports home and
community based waiver services shall be provided in accordance with the Centers for
Medicare and Medicaid’s “Appendix K: Emergency Preparedness and Response for
Home and Community Based (HCBS) 1915(c) Waivers” (effective March 2020 through
6 months after the end of the federal public health emergency), as available in
Appendix A.
Source. #13651, eff 5-26-23
He-C 5004.06 Confidentiality.
(a)
All services delivered via telehealth shall comply with all applicable
state and federal laws or regulations as allowed by the Medicaid program.
(b)
Privacy shall be maintained during all patient-provider interactions.
(c) All existing confidentiality requirements that
apply to medical records shall apply to services delivered by telehealth.
Source. #13651, eff 5-26-23
He-C 5004.07 Patient Rights and Consents.
(a)
The provider shall present the patient with basic information about the
services that the patient will be receiving via telehealth.
(b)
The patient shall provide his or her consent to participate in
services utilizing this technology.
(c) Telehealth
sessions shall not be recorded without the patient’s consent.
(d)
Culturally competent translation or interpretation services shall be
provided when the patient and the distant provider do not speak the same language.
(e)
Documentation in the patient’s medical record shall reflect that the
patient was informed of the patient’s rights policies which include the
following:
(1) The right to refuse to participate in
services delivered via telehealth;
(2) The role of the provider at the distant site
and the professional staff at the originating site who shall be responsible for
follow up or ongoing care;
(3) The city and state of the distant site
provider and all questions regarding the equipment and the technologies are
addressed;
(4) The right to be referred to in-person
emergency care when clinically appropriate;
(5) The right to be informed of all the parties
who shall be present at each end of the telehealth transmission; and
(6) The right to
know how an emergency would be handled by the provider during a telehealth
visit.
Source. #13651, eff 5-26-23
He-C 5004.08 Failure of
Transmission.
(a)
All telehealth providers shall have written procedures detailing a
contingency plan in the case of a failure of transmission or other technical difficulty that renders the service undeliverable.
(b) A claim for payment shall not be submitted to
Medicaid when the transmission fails.
Source. #13651, eff 5-26-23
He-C 5004.09 Non-Covered Services. Installation to provide telehealth services or
maintenance of telehealth hardware, software, or other equipment shall not be
covered by Medicaid.
Source. #13651, eff 5-26-23
He-C 5004.10 Prior Authorization. Telehealth services, including teledentistry,
shall be subject to the same prior authorization requirements as services
delivered via face to face.
Source. #13651, eff 5-26-23
He-C 5004.11 Utilization Review and Control. The department’s program integrity unit shall
monitor utilization of telehealth, including teledentistry services, to
identify, prevent, and correct potential occurrences of fraud, waste, and
abuse, in accordance with 42 CFR 455, CFR 456, and He-W 520.
Source. #13651, eff 5-26-23
He-C 5004.12 Third Party Liability. All third party obligations shall be
exhausted before Title XIX shall be billed, in accordance with 42 CFR 433.139.
Source. #13651, eff 5-26-23
He-C 5004.13 Payment for Services.
(a)
Payment to medical providers, described in He-C 5004.03 above, shall be
made in accordance with rates established by the department in accordance with
RSA 161:4, VI(a).
(b)
Services delivered via telehealth shall be reimbursed pursuant to RSA
167:4-d III(b) and (c).
(c)
Medical providers shall use appropriate CPT procedure codes and
modifiers when billing.
(d) Dental providers shall use CDT procedure codes
when billing.
(e)
All claims for payment shall be submitted to the department’s fiscal
agent.
(f)
All providers shall maintain supporting records in accordance with He-W
520.
(g) All providers shall be responsible for
determining that the recipient is Title XIX eligible on the date of service.
(h)
Payment for store and forward and remote
patient monitoring shall only be available as funding and
resources within the current state fiscal year are available.
Source. #13651, eff 5-26-23
PART
He-C 5005 through He-C 5009 - RESERVED
PART He-C
5010 DRUG USE REVIEW BOARD
He-C 5010.01 Purpose. The purpose of these rules is to describe the
establishment and operation of the New Hampshire drug use review board (DUR
board), created to comply with federal requirements of Section 4401 of the
Omnibus Budget Reconciliation Act of 1990 relative to pharmaceutical services
furnished under the medicaid fee for service (FFS) program and to comply with
Chapter 19 Laws of New Hampshire (2009).
Source. #5529, eff 12-16-92; ss by #6907, eff 12-9-98;
ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09; ss by #12460, eff 1-13-18
He-C 5010.02 Definitions.
(a)
“Commissioner” means the commissioner of the New Hampshire department of
health and human services, or his or her designee.
(b)
“Department” means the New Hampshire department of health and human
services (DHHS).
(c)
“Drug use review (DUR)” means a program designed to ensure that prescriptions
are appropriate, medically necessary, and not likely to result in adverse
medical results.
(d)
“DUR board” means an advisory board to the state’s medicaid pharmacy
program as required by the Omnibus Budget Reconciliation Act of 1990.
(e) “Medicaid” means the Title XIX and
Title XXI programs administered by the department which makes medical
assistance available to eligible individuals.
(f)
“Pharmacy benefit manager (PBM)” means the vendor representative designated
by the department to administer the medicaid pharmacy benefit for medicaid
recipients.
(g)
“Prescriber” means any professional whose licensure and scope of practice
permits prescribing medications.
(h)
“Provider” means an entity or individual who furnishes health care services
or supplies to medicaid recipients under a provider enrollment agreement with
the department, and is licensed or certified pursuant to applicable state law
and rules to provide such services and supplies.
(i)
“Recipient” means any individual who is eligible for and receiving
medical assistance under medicaid.
(j)
“Surveillance and utilization review subsystem (SURS)” means the function
within the department to assess the quality of care, services, or supplies
received by medicaid recipients and to ensure that accurate billing and proper reimbursement
has been made for the care, services, or supplies.
(k)
“Title XIX program” means the joint federal-state program described in
Title XIX of the Social Security Act and administered in New Hampshire by the
department, under the medicaid program.
(l) “Title XXI program”
means the joint federal-state program described in Title XXI of the Social
Security Act and administered in New Hampshire by the department under the
medicaid program.
Source. #5529, eff 12-16-92; ss by #6907, eff 12-9-98;
ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09; ss by #12460, eff 1-13-18
He-C 5010.03 DUR Board Composition.
(a)
Membership of the DUR board shall comply with 42 USC 1396r-8(g)(3)(B)
and be composed as follows:
(1) A total of 3 members shall be physicians,
currently licensed and actively practicing medicine in New Hampshire pursuant
to RSA 329; and
(2) A total of 3 members shall be pharmacists,
currently licensed and actively practicing in New Hampshire pursuant to RSA
318.
(b)
Each member shall possess one of the skills identified in 42 USC
1396r-8(3)(B)(i) and (ii), as well as one of the skills identified in 42 USC
1396r-8(3)(B)(iii) and (iv).
Source. #5529, eff 12-16-92; ss by #5608, eff 4-6-93;
ss by #6907, eff 12-9-98; ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09;
ss by #12460, eff 1-13-18
He-C 5010.04 Staff Support. The department shall name one staff person to
consult with the DUR board and participate in the DUR board’s deliberations.
This individual shall not be a voting member of the DUR board and shall not be
assigned to any drug-related SURS function within the department.
Source. #5529, eff 12-16-92; ss by #5608, eff 4-6-93;
ss by #6907, eff 12-9-98; ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09
(from He-C 5010.05); ss by #12460, eff 1-13-18
He-C 5010.05 Terms of Appointment.
(a)
Each member of the DUR board shall be appointed by the commissioner to
serve a 4 year term.
(b)
Any vacancy on the DUR board shall be filled by the commissioner’s
appointment of a person to serve the remainder of the current term. Such person
shall be from the same category described in He-C 5010.03(a) as the person
being replaced. All subsequent appointments shall be for 4-year terms.
(c)
Prior to appointment to the DUR board, each member shall provide a
current curriculum vitae to the department.
Source. #5529, eff 12-16-92; ss by #5608, eff 4-6-93;
ss by #6907, eff 12-9-98; ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09
(from He-C 5010.06); ss by #12460, eff 1-13-18
He-C 5010.06 Operation of the DUR Board. The DUR board shall establish and comply with
bylaws outlining procedures for accomplishing the following:
(a)
Selecting a chairperson;
(b)
Scheduling regular meetings;
(c)
Setting a quorum requirement of not less than 4 members;
(d)
Preparing notices of meetings consistent with RSA 91-A:2;
(e) Affirming that all DUR board activities are
consistent with applicable confidentiality requirements, and in accordance with
42 CFR 431, Part F;
(f)
Preparing and disseminating minutes of each meeting;
(g)
Preparing an annual report;
(h)
Reviewing and updating the bylaws; and
(i)
Other matters of internal governance, as necessary.
Source. #5529, eff 12-16-92; ss by #5608, eff 4-6-93;
ss by #6907, eff 12-9-98; ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09
(from He-C 5010.07); ss by #12460, eff 1-13-18
He-C 5010.07 Functions and Responsibilities of the DUR
Board.
(a)
The DUR board shall hold meetings no less than semi-annually.
(b)
Based on 42 USC 1396r-8(g)(1)(A) and (B), the DUR board shall make recommendations
to the commissioner regarding policy, procedures, and standards for the implementation
of the medicaid pharmacy benefit, the primary focus of which shall be the
education of providers and medicaid recipients to maximize the quality of care
provided.
(c)
The DUR board shall advise the commissioner regarding:
(1) The clinical operation of the pharmacy
benefit management program;
(2) Which medications are subject to prior
authorization, pursuant to He-C 5010.08(d); and
(3) The criteria required for prior authorization
to be granted, pursuant to He-C 5010.08(d).
(d)
The DUR board shall develop a retrospective DUR program in accordance
with the following:
(1) The DUR board shall recommend to the
commissioner the standards for the mechanized drug claims processing and
information retrieval system;
(2) The DUR board shall recommend
to the commissioner parameters for the PBM’s performance of ongoing periodic
examination of claims data and other records in order to identify patterns of
fraud, abuse, gross overuse, or inappropriate or medically unnecessary care
among prescribers, pharmacists, and recipients; and
(3) The DUR board
shall review recommendations of the PBM’s pharmacist and physician, which shall
be based upon evidence-based and peer-reviewed medical literature or at least
one of the following compendia:
a. American Hospital Formulary Service Drug
Information;
b. United States Pharmacopoeia-Drug Information;
or
c. American Medical Association Drug
Evaluations.
(e) In accordance with 42 USC 1396r-8(g)(3)(C), the DUR board shall recommend ongoing
educational interventions for:
(1) Prescribers and pharmacists, targeted toward
over use, under use, or misuse of pharmacy services or benefits; and
(2) Individuals identified in the course of
retrospective drug use reviews performed under (d) above.
(f)
Recommendations made pursuant to (e) above shall include:
(1) Information to prescribers and pharmacists
concerning the DUR board’s duties, functions, and responsibilities;
(2) Written, oral, or electronic
reminders concerning patient-specific or drug-specific information, or both,
with suggested changes in prescribing or dispensing practices, communicated in
a manner designated to ensure the privacy of patient-related information;
(3) The use of face-to-face discussions between health
care professionals who are experts in rational drug therapy and prescribers and
pharmacists who have been targeted for educational intervention; and
(4) The intensified review or monitoring of
prescribers or pharmacists who have been targeted for review under this
section.
(g)
The DUR board shall re-evaluate interventions as described in (f) above,
after a period of time which the DUR board has determined is sufficient, based
on the specific circumstances of the prescribing practice under review, to
determine if the interventions improved the quality of drug therapy, to
evaluate the success of the interventions, and to recommend modifications as
necessary.
(h)
The DUR board shall prepare an annual report to be provided to the
commissioner.
(i)
The annual report in (h) above shall include:
(1) A description
of the activities of the DUR board, including the nature and scope of the
prospective and retrospective DUR programs;
(2) A summary of the interventions used;
(3) An assessment of the impact of these
interventions on quality of care; and
(4) An estimate of the cost savings generated as
a result of such programs.
(j)
The DUR board shall advise the commissioner on the criteria for the
pharmacy lock-in program defined in He-W 570.01 and described more particularly
at He-W 570.07.
(k)
Other reports and data shall be provided by the DUR board to the
commissioner at such time and in such format as he or she requests.
Source. #5529, eff 12-16-92; amd by #5608, eff
4-6-93; ss by #6907, eff 12-9-98; ss by #8743, eff 10-24-06; ss by #9587, eff
11-4-09 (from He-C 5010.08); ss by #12460, eff 1-13-18
He-C 5010.08 Public Hearing Requirements. In furtherance of He-C 5010.07(c) above, the
DUR board shall:
(a)
Hold a public hearing, in accordance with RSA 91-A, 2002, 281:9, III, as
repealed and reenacted by 2003, 319:176, and 2009, 19:1, to afford opportunity
for the public to present its views regarding the components of the prior
authorization process and any changes thereto;
(b)
Give public notice of the DUR board hearing agenda as it relates to
prior authorized medications and any meeting date, time, and location in a
public notice advertisement in a publication of daily statewide circulation at
least 30 days in advance of the public meeting;
(c)
Make available at least 15 days in advance of the public hearing, the
specific proposed criteria or proposed changes to the list of medications
subject to prior authorization;
(d)
Conduct the hearing in accordance with the following:
(1) A record of the public hearing shall be kept
by electronic recording or other method that will provide a verbatim record;
(2) The presiding officer at the public hearing
shall be the medicaid pharmacy director or the individual designated by the
medicaid pharmacy director to preside at the hearing;
(3) The presiding officer shall
open the public hearing by describing in general terms the purpose of the
hearing and procedures governing its conduct; and
(4) Testimony at the public hearing shall adhere
to the following requirements:
a. Anyone wishing to submit
written testimony or exhibits at the public hearing shall submit them to the
presiding officer, provided such testimony or exhibit is signed and dated by
the individual submitting it;
b. Anyone wishing to testify at the public
hearing shall submit in writing to the presiding officer the person’s name,
address, and whom, if anyone, that person represents;
c. The presiding officer shall call each person
to present testimony; and
d. The presiding officer shall
rule any comments, questions, or discussions that the presiding officer determines
not to be relevant to the subject of the public hearing out of order, and
proceed to the next speaker; and
(e)
Recommend to the commissioner the components of the prior authorization
process and any changes thereto after considering the following, to the extent
reasonably available:
(1) Review of evidence-based comparative effectiveness
reviews addressing medications, to include consideration of diagnosis,
disease states, drug interactions, diagnostic testing, complicating medical
factors, and potential for abuse or misuse;
(2) Identification of the availability of more
cost effective, alternative medications;
(3) Clinical advantages, disadvantages, and
medical necessity for medications identified in (2) above;
(4) Identification of drug contraindications that
would affect the quality of care provided to recipients;
(5) Efficacy of available pharmaceuticals;
(6) Appropriate
clinical use of medications for recipients considering their individual
clinical circumstances including but not limited to age, gender, race,
comorbidities, and allergies; and
(7) Comments on components of the prior
authorization process submitted by the public for consideration.
Source. #5529, eff 12-16-92; amd by #5608, eff
4-6-93; ss by #6907, eff 12-9-98; ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09;
); ss by #12460, eff 1-13-18
He-C 5010.09 Independence of the DUR Board. The DUR board’s relationship to the SURS
program, to the board of medicine, and to the board of pharmacy shall be as
follows:
(a)
The DUR board shall not directly participate in any SURS operation or
activities except to the extent that educational materials prepared by the DUR
board are provided to the department, as they are to providers, recipients, and
the public;
(b)
The DUR board shall not involve itself as an entity in any individual
cases relating to professional conduct or practice standards that might be
before the board of medicine, the board of pharmacy, or other regulatory or
oversight boards or bodies; and
(c)
If the DUR board finds evidence of continuing fraud, abuse, or gross
misuse by medicaid providers after the implementation of educational
interventions pursuant to He-C 5010.08(c), they shall be referred to the
department for further action.
Source. #5529, eff 12-16-92; ss by #6907, eff 12-9-98;
ss by #8743, eff 10-24-06; ss by #9587, eff 11-4-09 ss by #12460, eff 1-13-18
PART He-C 5011
Statutory
authority: RSA 167:18-a, III(b)
He-C 5011.01 - 5011.04
Source. #9190, INTERIM, eff 7-1-08, EXPIRED: 12-28-08
APPENDIX A
Rule |
Title |
Publisher; How to Obtain; and
Cost |
He-C 5004.05(d), (e), and (f) |
Centers for Medicare and Medicaid’s,
“Appendix K: Emergency Preparedness and Response for Home and Community Based
(HCBS) 1915(c) Waivers” (March 2020) |
Publisher: Centers for Medicare and Medicaid Cost: Free of Charge The incorporated document is available at: https://www.medicaid.gov/resources-for-states/disaster-response-toolkit/home-community-based-services-public-health-emergencies/emergency-preparedness-and-response-for-home-and-community-based-hcbs-1915c-waivers/index.html#:~:text=Appendix%20K%20is%20a%20standalone%20appendix%20that%20may,authority%20in%20order%20to%20respond%20to%20an%20emergency. |
APPENDIX B
Rule |
Specific State Statute the Rule
Implements |
|
|
He-C
5001 |
RSA
167:63-65 |
He-C
5002 |
RSA
167:63-65 |
He-C 5003.01 -
5003.02 |
RSA 167:6, IX;
Section 1902 (a) (10) (A) (ii) (XV), Ticket to Work and Work Incentives Improvement
Act |
|
|
He-C
5004.01-5004.03 |
RSA 167:4-d, |
He-C 5004.04 |
42 CFR
440.230(d) |
He-C 5004.05 |
RSA 167:4-d; 42
CFR 440.230 |
He-C 5004.06 |
RSA 161:2-VI |
He-C 5004.07 |
RSA 161:4, X(m) |
He-C 5004.08 |
RSA 161:4, X(l) |
He-C 5004.09 |
42 CFR 440.230(d);
RSA 541-A; 21, VIII |
He-C 5004.10 |
42 CFR
440.230(d); 42 CFR 431.107; RSA 126-A:5, VII |
He-C 5004.11 |
42 CFR 455; 42
CFR 456 |
He-C 5004.12 |
42 CFR 433.139 |
He-C 5004.13 |
42 CFR 447.15;
RSA 161:4, VI(a); RSA 167:4-d, III (b) and (c) |
|
|
He-C 5010 All
sections |
Laws of 2009,
19:1 |
|
|
He-C
5010.01 |
42
CFR 456.716; Section 4401 of OBRA 1990 |
He-C
5010.02 |
42
CFR 456, Subpart K |
He-C
5010.03 |
42
CFR 456.716(a) & (b); Section 1396r-8(g)(3)(B) of the SS Act |
He-C
5010.04 |
42
CFR 456.716(b); Section 1396r-8(g)(3)(B) of the SS Act |
He-C
5010.05 |
42
CFR 456.716(a) |
He-C
5010.06 |
42
CFR 456.716(b) |
He-C
5010.07 |
Section
1396r-8(g)(3)(C) & (D) of the SS Act; 42 CFR 456.712 |
He-C
5010.08 |
Section
1396r-8(g)(3)(C) & (D) of the SS Act; 42 CFR 456.716(d); 42 CFR 456.709 |
He-C
5010.09 |
42
CFR 456.714 |
He-C
5011.01 and 5011.02 |
RSA 167:18-a |
He-C
5011.03 |
RSA 167:18-a, III(a)(1) |
He-C
5011.04 |
RSA 167:18-a, III(a)(1) and (b) |